Armenia grants marketing authorizations for Agenus BOT+BAL

Agenus said Armenia’s Ministry of Health granted marketing authorizations for Botvymo (botensilimab, BOT) and Evamplix (balstilimab, BAL) for use together in previously treated metastatic colorectal cancer.